These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 26106176

  • 1. Diffuse idiopathic skeletal hyperostosis and isotretinoin in cystic acne.
    Zhao S, Goodson NJ.
    BMJ Case Rep; 2015 Jun 23; 2015():. PubMed ID: 26106176
    [Abstract] [Full Text] [Related]

  • 2. What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH?
    Ling TC, Parkin G, Islam J, Seukeran DC, Cunliffe WJ.
    Br J Dermatol; 2001 Mar 23; 144(3):630-2. PubMed ID: 11260033
    [No Abstract] [Full Text] [Related]

  • 3. Isotretinoin effects on bone.
    DiGiovanna JJ.
    J Am Acad Dermatol; 2001 Nov 23; 45(5):S176-82. PubMed ID: 11606950
    [Abstract] [Full Text] [Related]

  • 4. Diffuse idiopathic skeletal hyperostosis in a young woman treated with isotretinoin.
    Ibáñez Barceló M, Estremera Rodrigo A, Ros Vilamajó I, Juan Mas A.
    Reumatol Clin (Engl Ed); 2022 Mar 23; 18(3):184-185. PubMed ID: 35277216
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L, Aksu Arıca D, Baykal Şahin H, Yaylı S, Bahadır S.
    Cutan Ocul Toxicol; 2017 Jun 23; 36(2):176-179. PubMed ID: 27764978
    [Abstract] [Full Text] [Related]

  • 6. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
    DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe NJ, Eichenfield L, Hebert AA, Pariser D, Savin RP, Smith SR, Jarratt M, Rodriguez D, Chalker DK, Kempers S, Ling M, Rafal ES, Sullivan S, Kang S, Shah LP, Wu E, Newhouse J, Pak J, Eberhardt DR, Bryce GF, McLane JA, Ondovik M, Chin C, Khoo KC, Rich P.
    J Am Acad Dermatol; 2004 Nov 23; 51(5):709-17. PubMed ID: 15523348
    [Abstract] [Full Text] [Related]

  • 7. Coexistence of ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: another report.
    Olivieri I, Trippi D, Gherardi S, Pasero G.
    J Rheumatol; 1987 Oct 23; 14(5):1058-60. PubMed ID: 3501468
    [Abstract] [Full Text] [Related]

  • 8. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E, Massie J, Phillips RJ.
    Arch Dis Child; 2009 Aug 23; 94(8):583-6. PubMed ID: 19465582
    [Abstract] [Full Text] [Related]

  • 9. Inflammatory back pain in patients treated with isotretinoin.
    Pehlivan Y, Kisacik B, Sayiner ZA, Onat AM.
    J Rheumatol; 2011 Dec 23; 38(12):2690. PubMed ID: 22134798
    [No Abstract] [Full Text] [Related]

  • 10. Diffuse idiopathic skeletal hyperostosis in a Nigerian (DISH Forestier's disease, ankylosing hyperostosis): a case report.
    Adelowo OO.
    West Afr J Med; 1994 Dec 23; 13(4):248-9. PubMed ID: 7756195
    [Abstract] [Full Text] [Related]

  • 11. Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy.
    Atalay A, Altaykan A, Ergin G, Kutsal YG.
    Rheumatol Int; 2004 Sep 23; 24(5):297-300. PubMed ID: 13680140
    [Abstract] [Full Text] [Related]

  • 12. [Systemic retinoid therapy in severe acne infantum].
    Hütten M, Baron JM, Ott H.
    Hautarzt; 2008 Jun 23; 59(6):454-7. PubMed ID: 18470501
    [No Abstract] [Full Text] [Related]

  • 13. Diffuse idiopathic skeletal hyperostosis and situs viscerum inversus.
    Carile L, Verdone F, Aiello A, Buongusto G.
    J Rheumatol; 1989 Aug 23; 16(8):1120-2. PubMed ID: 2585410
    [Abstract] [Full Text] [Related]

  • 14. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD, Rallis E.
    J Eur Acad Dermatol Venereol; 2007 Oct 23; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract] [Full Text] [Related]

  • 15. Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin.
    Tangrea JA, Kilcoyne RF, Taylor PR, Helsel WE, Adrianza ME, Hartman AM, Edwards BK, Peck GL.
    Arch Dermatol; 1992 Jul 23; 128(7):921-5. PubMed ID: 1626958
    [Abstract] [Full Text] [Related]

  • 16. Retrospective case series of isotretinoin outcomes for acne in 393 female patients at Baylor College of Medicine during 2012-2016.
    Fernandez J, Lee B, Patel JM, Weiss E, Jiang J, Dao H, Kim SJ.
    J Am Acad Dermatol; 2020 May 23; 82(5):1218-1219. PubMed ID: 31443910
    [No Abstract] [Full Text] [Related]

  • 17. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR.
    Australas J Dermatol; 2011 May 23; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract] [Full Text] [Related]

  • 18. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Layton AM, Dréno B, Gollnick H, Mobaken H, Shear N.
    Br J Dermatol; 2009 Jan 23; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
    [No Abstract] [Full Text] [Related]

  • 19. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V.
    Dermatology; 2009 Jan 23; 218(2):178-80. PubMed ID: 19060474
    [No Abstract] [Full Text] [Related]

  • 20. Night blindness following low-dose isotretinoin.
    Halpagi P, Grigg J, Klistorner A, Damian DL.
    J Eur Acad Dermatol Venereol; 2008 Jul 23; 22(7):893-4. PubMed ID: 18031494
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.